Retatrutide (LY3437943) is currently in Phase 3 clinical trials and is not yet FDA-approved
Anti-Inflammatory Properties This copper peptide is often described as anti-inflammatory in popular summaries, but the research paints a more nuanced picture
In this analysis, prescription patterns were not affected by patient insurance status, suggesting that practitioner knowledge of benefit or indications for use were stark barriers [130]
Drug Interactions The concomitant use of JANUMET XR with specific drugs may increase the risk of metformin-associated lactic acidosis: those that impair renal function, result in significant hemodynamic change, interfere with acid-base balance or increase metformin accumulation [see Drug Interactions (7)]
FAQs What are GLP-1 medications GLP-1 medications (like Semaglutide, Tirzepatide, and Liraglutide) help regulate blood sugar and reduce appetite, leading to effective and sustained weight loss